Menu
X

Clinical trials

  1. CAPItello-281 (AstraZeneca)

Capivasertib + Abiraterone as Treatment for Patients with Metastatic Hormone-Sensitive Prostate Cancer Characterised by PTEN deficiency.

Protocol Title and Summary

Summary of Eligibility Criteria

Contact:  Junaid Maloko – Netcare Millpark | Tel +27 10 020 2428 | Junaid.maloko@peermedctc.com

Coming soon…

Coming soon…

Coming soon…

Coming soon…

Coming soon…

All Rights Reserved. Temple | Wisdom Online | Privacy Policy